Ippei Miyata

578 total citations
26 papers, 348 citations indexed

About

Ippei Miyata is a scholar working on Epidemiology, Infectious Diseases and Microbiology. According to data from OpenAlex, Ippei Miyata has authored 26 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 7 papers in Infectious Diseases and 7 papers in Microbiology. Recurrent topics in Ippei Miyata's work include Respiratory viral infections research (7 papers), Pneumonia and Respiratory Infections (7 papers) and Microbial infections and disease research (6 papers). Ippei Miyata is often cited by papers focused on Respiratory viral infections research (7 papers), Pneumonia and Respiratory Infections (7 papers) and Microbial infections and disease research (6 papers). Ippei Miyata collaborates with scholars based in Japan, Australia and Mexico. Ippei Miyata's co-authors include Isao Miyairi, Akihiko Saitoh, Kensuke Shoji, Kazunobu Ouchi, Tomohiro Oishi, Naoki Ohno, Atsushi Kato, Hiroto Akaike, Eisuke Kondo and Hideto Teranishi and has published in prestigious journals such as PEDIATRICS, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

Ippei Miyata

26 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ippei Miyata Japan 10 230 98 94 69 33 26 348
Manuela Zlamy Austria 13 130 0.6× 108 1.1× 41 0.4× 67 1.0× 96 2.9× 30 423
Lena Wehlin Sweden 9 145 0.6× 86 0.9× 107 1.1× 55 0.8× 84 2.5× 11 385
Mildred A. Iro United Kingdom 9 118 0.5× 78 0.8× 83 0.9× 34 0.5× 12 0.4× 15 210
Wenxia Shao China 12 130 0.6× 67 0.7× 34 0.4× 10 0.1× 68 2.1× 19 322
Hüseyin Kılıç Türkiye 10 79 0.3× 32 0.3× 15 0.2× 30 0.4× 37 1.1× 50 294
Gregory Judson United States 8 55 0.2× 22 0.2× 104 1.1× 42 0.6× 47 1.4× 14 250
Tobias Brummaier Thailand 10 74 0.3× 25 0.3× 39 0.4× 19 0.3× 31 0.9× 29 258
F. Raschilas France 4 342 1.5× 200 2.0× 55 0.6× 23 0.3× 36 1.1× 16 454
Huifeng Fan China 14 223 1.0× 101 1.0× 52 0.6× 8 0.1× 136 4.1× 42 480
Hiroaki Ioi Japan 11 152 0.7× 160 1.6× 44 0.5× 56 0.8× 31 0.9× 23 307

Countries citing papers authored by Ippei Miyata

Since Specialization
Citations

This map shows the geographic impact of Ippei Miyata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ippei Miyata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ippei Miyata more than expected).

Fields of papers citing papers by Ippei Miyata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ippei Miyata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ippei Miyata. The network helps show where Ippei Miyata may publish in the future.

Co-authorship network of co-authors of Ippei Miyata

This figure shows the co-authorship network connecting the top 25 collaborators of Ippei Miyata. A scholar is included among the top collaborators of Ippei Miyata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ippei Miyata. Ippei Miyata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miyata, Ippei, Atsushi Kato, & Kazunobu Ouchi. (2022). Evaluation of anti-Yersinia psueudotuberculosis-derived mitogen antibody in intravenous immunoglobulin products. Journal of Infection and Chemotherapy. 28(11). 1582–1583. 1 indexed citations
2.
Oishi, Tomohiro, Y. Fukuda, Atsushi Kato, et al.. (2021). Analysis of risk factors for multidrug-resistant pathogens and appropriate treatment indications for pneumonia in children with neurologic impairment. Journal of Infection and Chemotherapy. 27(2). 342–347. 5 indexed citations
3.
Kakiuchi, Toshihiko, Ippei Miyata, Reiji Kimura, et al.. (2021). Clinical Evaluation of a Novel Point-of-Care Assay To Detect Mycoplasma pneumoniae and Associated Macrolide-Resistant Mutations. Journal of Clinical Microbiology. 59(7). e0324520–e0324520. 11 indexed citations
4.
Oishi, Tomohiro, et al.. (2021). Epidemiology of urinary tract infections in children: Causative bacteria and antimicrobial therapy. Pediatrics International. 63(10). 1198–1204. 4 indexed citations
5.
Miyata, Ippei, Yoshitaka Nakamura, Eisuke Kondo, et al.. (2021). Characteristics and etiology of infection in febrile infants aged ≤90 days. Pediatrics International. 64(1). e15040–e15040. 2 indexed citations
6.
Oishi, Tomohiro, Y. Fukuda, Shoko Wakabayashi, et al.. (2020). Low prevalence of Chlamydia pneumoniae infections during the Mycoplasma pneumoniae epidemic season: Results of nationwide surveillance in Japan. Journal of Infection and Chemotherapy. 26(11). 1116–1121. 8 indexed citations
7.
Nakamura, Yoshitaka, Tomohiro Oishi, Kazunari Kaneko, et al.. (2020). Recent acute reduction in macrolide-resistant Mycoplasma pneumoniae infections among Japanese children. Journal of Infection and Chemotherapy. 27(2). 271–276. 25 indexed citations
8.
Kato, Atsushi, Ippei Miyata, Tomohiro Oishi, et al.. (2019). LAMP-based assay can rectify the diagnosis of Yersinia pseudotuberculosis infections otherwise missed by serology. Journal of Medical Microbiology. 68(2). 143–147. 3 indexed citations
9.
Sakurai, Akira, Takashi Ogawa, Jun Matsumoto, et al.. (2019). Regulatory aspects of quality and safety for live recombinant viral vaccines against infectious diseases in Japan. Vaccine. 37(43). 6573–6579. 4 indexed citations
10.
Teranishi, Hideto, Ippei Miyata, Shoko Wakabayashi, et al.. (2018). Incidence of Viremia With DNA Viruses in Oncology Patients With Febrile Neutropenia. Journal of Pediatric Hematology/Oncology. 40(8). 605–608. 4 indexed citations
11.
Tanaka, Takaaki, Tomohiro Oishi, Ippei Miyata, et al.. (2017). Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008–2015. Emerging infectious diseases. 23(10). 1703–1706. 73 indexed citations
12.
Tomida, Junko, et al.. (2016). Helicobacter cinaedi bacteremia resulting from antimicrobial resistance acquired during treatment for X-linked agammaglobulinemia. Journal of Infection and Chemotherapy. 22(10). 704–706. 10 indexed citations
13.
Funaki, Takanori, Kensuke Shoji, Ippei Miyata, et al.. (2015). Serostatus following live attenuated vaccination administered before pediatric liver transplantation. Liver Transplantation. 21(6). 774–783. 14 indexed citations
14.
Funaki, Takanori, Ippei Miyata, Kensuke Shoji, et al.. (2015). Therapeutic Drug Monitoring in Neonatal HSV Infection on Continuous Renal Replacement Therapy. PEDIATRICS. 136(1). e270–e274. 5 indexed citations
15.
Miyata, Ippei, Takahiko Kubo, Isao Miyairi, Akihiko Saitoh, & Noriko Morimoto. (2014). Successful Detection and Genotyping of Rubella Virus From Preserved Umbilical Cord of Patients With Congenital Rubella Syndrome. Clinical Infectious Diseases. 60(4). 605–607. 3 indexed citations
16.
Miyata, Ippei, Nozomu Hanaoka, Tsuguto Fujimoto, et al.. (2013). Echovirus 3 as another enterovirus causing life-threatening neonatal fulminant hepatitis. Journal of Clinical Virology. 59(2). 132–134. 9 indexed citations
17.
Shoji, Kensuke, Yoshinori Kobayashi, Takanori Funaki, et al.. (2012). An Infant with Human Parechovirus Type 3 Infection with a Distinctive Rash on the Extremities. Pediatric Dermatology. 31(2). 258–259. 16 indexed citations
18.
Sato, Mai, Shuichi Ito, Masao Ogura, et al.. (2012). Atypical Pneumocystis jiroveci pneumonia with multiple nodular granulomas after rituximab for refractory nephrotic syndrome. Pediatric Nephrology. 28(1). 145–149. 37 indexed citations
19.
Shoji, Kensuke, et al.. (2012). Dermatologic Manifestations of Human Parechovirus Type 3 Infection in Neonates and Infants. The Pediatric Infectious Disease Journal. 32(3). 233–236. 49 indexed citations
20.
Miyata, Ippei, et al.. (2011). Seizure‐modifying potential of histamine H1 antagonists: A clinical observation. Pediatrics International. 53(5). 706–708. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manuela Zlamy Breakdown of academic impact, for papers by Lena Wehlin Breakdown of academic impact, for papers by Mildred A. Iro Breakdown of academic impact, for papers by Wenxia Shao Breakdown of academic impact, for papers by Hüseyin Kılıç Breakdown of academic impact, for papers by Gregory Judson Breakdown of academic impact, for papers by Tobias Brummaier Breakdown of academic impact, for papers by F. Raschilas Breakdown of academic impact, for papers by Huifeng Fan Breakdown of academic impact, for papers by Hiroaki Ioi
Rankless by CCL
2026